S
Sina Bavari
Researcher at United States Army Medical Research Institute of Infectious Diseases
Publications - 353
Citations - 21495
Sina Bavari is an academic researcher from United States Army Medical Research Institute of Infectious Diseases. The author has contributed to research in topics: Ebola virus & Virus. The author has an hindex of 69, co-authored 349 publications receiving 18782 citations. Previous affiliations of Sina Bavari include University of Nebraska Medical Center & Walter Reed Army Institute of Research.
Papers
More filters
Patent
Inhibition of anthrax lethal factor protease
TL;DR: In this article, a pharmacophore model for inhibiting anthrax lethal factor protease activity is presented, which consists of a first aromatic center A, a second aromatic center B, a first polar center C, another polar center D, a third polar center E, and a neutral linker F.
High Infection Rates in Adult Macaques Following Intravaginal or Intrarectal Zika Virus Inoculation
Andrew D. Haddow,Aysegul Nalca,Franco Rossi,Lynn J. Miller,Michael R. Wiley,Unai Pérez-Sautu,Samuel C. Washington,Sarah L. Norris,Suzanne E. Wollen-Roberts,Joshua D. Shamblin,Adrienne E. Kimmel,Holly A. Bloomfield,Stephanie M. Valdez,Thomas R. Sprague,Lucia M. Principe,Stephanie A. Bellanca,Stephanie S. Cinkovich,Luis A. Lugo-Roman,Lisa H. Cazares,William D. Pratt,Gustavo Palacios,Sina Bavari,Margaret L. Pitt,Farooq Nasar +23 more
TL;DR: Authors: Andrew D. Haddow*, Aysegul Nalca, Franco D. Rossi, Lynn J. Miller, Michael R. Wiley, Unai Perez-Sautu, Samuel C. Washington, Sarah L. Norris, Suzanne E. WollenRoberts, Joshua D. Shamblin, Adrienne E. Bloomfield, Stephanie M. Sprague, Lucia M. Principe.
Patent
Compositions de benzonapthyridine et leurs utilisations
TL;DR: In this article, a petite molecule (SMIP) of type benzonapthyridine is presented, which is capable of stimuler ou moduler une reponse immunitaire chez un sujet qui a eu une pre ou post-exposition a pathogene tel que le virus de la fievre hemorragique.
Posted ContentDOI
DDX3 is exploited by Arenaviruses to suppress type I interferons and favor their replication
Maria Eugenia Loureiro,Andre Luiz Zorzetto-Fernandes,Sheli R. Radoshitzky,Xiaoli Chi,Simone Dallari,Nuha Marooki,Psylvia Leger,Sabrina Foscaldi,Sonia Sharma,Nora López,de la Torre Jc,Sina Bavari,Elina I. Zuniga +12 more
TL;DR: This study established DDX3 as a critical host interacting partner of the arenavirus nucleoprotein and demonstrated two previously unrecognizedDDX3-dependent strategies by which these deadly viruses exploit the host cellular machinery and suppress immunity.